Literature DB >> 3266556

Human alpha-calcitonin gene-related peptide (CGRP) is a potent vasodilator in human mesenteric vasculature.

I Marshall1, S J Al-Kazwini, J J Holman, R K Craig.   

Abstract

1. The effect of human alpha-calcitonin gene-related peptide (CGRP) and sodium nitroprusside have been measured on human isolated mesenteric vasculature and on rings of human superior mesenteric artery and saphenous vein. 2. When noradrenaline (10(-5) M) was used as the vasoconstrictor in preparations perfused with Krebs solution at constant flow, human alpha-CGRP was 10 times more potent than sodium nitroprusside in evoking dose-dependent falls in perfusion pressure. 3. Human alpha-CGRP and sodium nitroprusside were about equipotent at relaxing rings of superior mesenteric artery contracted by noradrenaline (10(-6) M). When the tone of saphenous vein rings was raised by noradrenaline (10(-6) M), human alpha-CGRP did not relax the vascular smooth muscle. 4. The results show that human alpha-CGRP is a potent vasodilator in human arterial preparations and may act preferentially on arterioles rather than large arteries.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266556      PMCID: PMC1386582          DOI: 10.1111/j.1365-2125.1988.tb05306.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  A second human calcitonin/CGRP gene.

Authors:  P H Steenbergh; J W Höppener; J Zandberg; C J Lips; H S Jansz
Journal:  FEBS Lett       Date:  1985-04-22       Impact factor: 4.124

2.  Alternative RNA processing: determining neuronal phenotype.

Authors:  M G Rosenfeld; S G Amara; R M Evans
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

3.  Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma.

Authors:  P H Steenbergh; J W Höppener; J Zandberg; W J Van de Ven; H S Jansz; C J Lips
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

4.  Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.

Authors:  S Schifter; E D Williams; R K Craig; H H Hansen
Journal:  Clin Endocrinol (Oxf)       Date:  1986-12       Impact factor: 3.478

5.  Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression.

Authors:  V Jonas; C R Lin; E Kawashima; D Semon; L W Swanson; J J Mermod; R M Evans; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Calcitonin gene-related peptide in cardiovascular tissues of the rat.

Authors:  P K Mulderry; M A Ghatei; J Rodrigo; J M Allen; M G Rosenfeld; J M Polak; S R Bloom
Journal:  Neuroscience       Date:  1985-03       Impact factor: 3.590

7.  Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones.

Authors:  M E Kraenzlin; J L Ch'ng; P K Mulderry; M A Ghatei; S R Bloom
Journal:  Regul Pept       Date:  1985-03

8.  Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.

Authors:  M G Rosenfeld; J J Mermod; S G Amara; L W Swanson; P E Sawchenko; J Rivier; W W Vale; R M Evans
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

9.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

10.  Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma.

Authors:  M R Edbrooke; D Parker; J H McVey; J H Riley; G D Sorenson; O S Pettengill; R K Craig
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  4 in total

1.  Splanchnic and cerebral vasodilatory effects of calcitonin gene-related peptide I in humans.

Authors:  M W Mulholland; M S Sarpa; J Delvalle; L M Messina
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

2.  Differential effects of (+/-)-dobutamine and human alpha-CGRP on cardiac and on regional haemodynamics in conscious Long Evans rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett; B Hughes; R Foulkes
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

3.  Effects of vasoactive neuropeptides on human saphenous vein.

Authors:  T N Luu; A H Chester; G S O'Neil; S Tadjkarimi; M H Yacoub
Journal:  Br Heart J       Date:  1992-06

Review 4.  The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects.

Authors:  Zizheng Kee; Xenia Kodji; Susan D Brain
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.